Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: results of a multicenter study from China

Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: results of a multicenter study from China

Abstract Little is known about the outcome for HIV-associated Hodgkin lymphoma (HIV-HL) as this is less common than HIV-negative lymphoma. Therefore, we performed a multi-center study to analyze the clinical characteristics and outcomes of HIV-HL patients in China. Nineteen cases of HIV-HL were diag...

Full description

Bibliographic Details
Main Authors: Lirong Xiao, Chaoyu Wang, Sai Ma, Yifan Wang, Liping Guan, Juyi Wu, Wei Zhang, Yao Liu, Yan Wu
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Infectious Agents and Cancer
Subjects:
HIV
Hodgkin lymphoma
cART
Treatment
Prognosis
Online Access:https://doi.org/10.1186/s13027-024-00571-w

Internet

https://doi.org/10.1186/s13027-024-00571-w

Similar Items